by | Feb 2014
A common view is that investors view steady firm-level R&D investment as evidence of the firm’s commitment to R&D-based innovation. However, recent research shows that R&D expenditure volatility is positively related to firm performance, suggesting that... by | Feb 2014
In recent years pharmaceutical companies have implemented Operational Excellence (OpEx) in their R&D organizations to improve productivity but had only limited success. Practitioners and management start to question the effectiveness of process- focused... by | Feb 2014
The forecasted bioplastic production capacity has signaled a strong growth in the next years, but with higher participation of drop-ins. Drop-in bioplastics are nonbiodegradable materials, identical to their fossil counterparts although obtained from renewable raw... by | Oct 2013
Abstract In the commercial area, classification of chemicals is not as straightforward as in the scientific area. Depending on the perspective taken, different levels can be utilized – moving from segments consisting of individual chemical compounds to the other... by | Oct 2013
Abstract The paper discusses the findings of a survey which was conducted in 2012 by ConMoto Consulting Group among top managers in German speaking countries. The aim of the survey was to analyze the value orientation of companies from a variety of industrial sectors,...